Profil
Jean-Michel Carle is currently a Member-Supervisory Board & General Manager at Eurobio-Scientific SA. Previously, he held the position of Chief Executive Officer at Eurobio SAS from 2017 to 2018 and Chairman & Chief Executive Officer at Eurobio Ingen SA from 2017 to 2018.
He also served as Chairman at Capforce Plus SAS and Director-Commercial & Sales at Theradiag SA.
Postes actifs de Jean-Michel Carle
| Sociétés | Poste | Début |
|---|---|---|
| EUROBIO SCIENTIFIC | Director/Board Member | 01/01/2023 |
Anciens postes connus de Jean-Michel Carle
| Sociétés | Poste | Fin |
|---|---|---|
Eurobio SAS
 Eurobio SAS Pharmaceuticals: MajorHealth Technology Eurobio SAS develops and distributes reagents for research as well for biomedical diagnosis. It works closely with scientists in research institutes including CNRS, INSERM, INRA, CNEVA, alongside life science companies, universities, hospitals and medical laboratories. The firm has two operating divisions: Life Sciences and Diagnostics managed by high-performing staff. The company was founded by Stephane Réveilleau on 1962 and is headquartered in Courtaboeuf, France. | Chief Executive Officer | 01/01/2018 |
Eurobio Ingen SA
 Eurobio Ingen SA Medical SpecialtiesHealth Technology Eurobio Ingen SA develops, manufactures, and markets reagents for research and biomedical diagnosis. The private company is based in Rungis, France. Jean-Michel Carle has been the CEO of the French company since 2017. | Chief Executive Officer | 01/01/2018 |
| THERADIAG | Sales & Marketing | - |
Capforce Plus SAS
 Capforce Plus SAS Medical SpecialtiesHealth Technology Capforce Plus SAS is a French company that manufactures IVD equipment. The private company is based in Les Ulis, France. Denis Fortier has been the CEO of the company since 2014. | Chairman | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EUROBIO SCIENTIFIC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
Eurobio SAS
Eurobio SAS Pharmaceuticals: MajorHealth Technology Eurobio SAS develops and distributes reagents for research as well for biomedical diagnosis. It works closely with scientists in research institutes including CNRS, INSERM, INRA, CNEVA, alongside life science companies, universities, hospitals and medical laboratories. The firm has two operating divisions: Life Sciences and Diagnostics managed by high-performing staff. The company was founded by Stephane Réveilleau on 1962 and is headquartered in Courtaboeuf, France. | Health Technology |
Capforce Plus SAS
Capforce Plus SAS Medical SpecialtiesHealth Technology Capforce Plus SAS is a French company that manufactures IVD equipment. The private company is based in Les Ulis, France. Denis Fortier has been the CEO of the company since 2014. | Health Technology |
Eurobio Ingen SA
Eurobio Ingen SA Medical SpecialtiesHealth Technology Eurobio Ingen SA develops, manufactures, and markets reagents for research and biomedical diagnosis. The private company is based in Rungis, France. Jean-Michel Carle has been the CEO of the French company since 2017. | Health Technology |
